Relationship between membrane depolarization and extracellular calcium influx during neutrophil activation.
To better define the relationship between membrane depolarization and extracellular Ca2+ influx during neutrophil activation, we compared stimulation by elevating the extracellular K+ concentration, [K+]o, with stimulation by the chemoattractant N-formyl-methionyl-leucyl-phenylalanine (fMLP). Elevation of [K+]o resulted in uniform depolarization of the entire population of cells. This was associated with an influx of Ca2+ that was temporally delayed and quantitatively less than that induced by fMLP. K+ depolarization also caused increased expression of type 1 (C3b/C4b) complement receptor (CR1) and type 3 (C3bi) complement receptor (CR3), but the increments were less than with fMLP. We then used pertussis toxin to determine if guanosine triphosphate (GTP)-binding proteins were involved in these responses. Toxin inhibited the fMLP-induced membrane depolarization as well as the uptake of extracellular Ca2+ and the expression of both CR1 and CR3 induced by the chemoattractant. This indicates that the fMLP receptor is not directly coupled to an ion channel. The membrane depolarization induced by elevating [K+]o was not inhibited by toxin, but the uptake of Ca2+ and the increased expression of CR1 and CR3 were all significantly inhibited. The toxin failed to block increased CR1 and CR3 expression induced by ionomycin, demonstrating that its effects were not attributable to general toxicity. The results suggest that voltage gating is not the major mechanism by which polymorphonuclear leukocytes (PMNs) increase their permeability to extracellular Ca2+. Initial signals, whether generated by chemoattractants binding to their receptors or by small initial influxes of extracellular Ca2+, must be amplified by pertussis toxin-sensitive steps to fully increase the Ca2+ permeability and optimally activate the cell.
Berger
M
M
Department of Pediatrics, Case Western Reserve University School of Medicine, Cleveland, OH 44106.
Birx
D L
DL
D002118:Calcium / Q000378:metabolism*; D002462:Cell Membrane / Q000502:physiology; D004594:Electrophysiology; D004987:Ethers / Q000494:pharmacology; D005110:Extracellular Space / Q000378:metabolism*; D006801:Humans; D015759:Ionomycin; D009240:N-Formylmethionine Leucyl-Phenylalanine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D009504:Neutrophils / Q000378:metabolism / Q000502:physiology*; D009994:Osmolar Concentration; D037342:Pertussis Toxin; D011188:Potassium / Q000378:metabolism / Q000494:pharmacology; D011951:Receptors, Complement / Q000378:metabolism; D010566:Virulence Factors, Bordetella / Q000494:pharmacology
D004987:Ethers; D011951:Receptors, Complement; D010566:Virulence Factors, Bordetella; D015759:Ionomycin; D009240:N-Formylmethionine Leucyl-Phenylalanine; D037342:Pertussis Toxin; D011188:Potassium; D002118:Calcium